for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Breakingviews

Breakingviews: LabCorp fails the M&A test

Posted

Antony Currie and Robert Cyran explain why the bloodwork firm's $6.1 bln deal for Covance has questionable strategic rationale – and why it's overpaying by some $700 mln.

Breakingviews

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up